The Dextrose Injection, cataloged under National Stock Number 6505-01-655-9395, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Baxter Healthcare Corporation. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: CS.
| Parameter | Value |
|---|---|
| NSN | 6505-01-655-9395 |
| Primary Part Number | 2B0064X |
| Item Name | Dextrose Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Baxter Healthcare Corporation |
| Status | ACTIVE |
| Administration | INTRAVENOUS |
| Primary Container Content Quantity | 1000.0 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | BAG, PLASTIC |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 5.0 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | CS |
| Part Number | Manufacturer |
|---|---|
| 2B0064X PRIMARY | Baxter Healthcare Corporation (USA) |
| NDC00338-0017-04 PRIMARY | Baxter Healthcare Corporation (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM162885 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1411801 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-655-9395 is a Dextrose Injection, manufactured by Baxter Healthcare Corporation, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-655-9395 has 2 manufacturer part numbers on file: 2B0064X (Baxter Healthcare Corporation), NDC00338-0017-04 (Baxter Healthcare Corporation).
Key specifications for 2B0064X: Administration: INTRAVENOUS; Primary Container Content Quantity: 1000.0 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Features Provided: STERILE. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.